GIFLF
GRIFOLS SA BARC ORD NEW by Grifols Sa (GIFLF)
$
50About GRIFOLS SA BARC ORD NEW by Grifols Sa (GIFLF)
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$11.39
52 Week Low
$8.40
Market cap
5.8B
Dividend yield
0.00%
Volume
--
Avg. volume
168
P/E ratio
33.89
GRIFOLS SA BARC ORD NEW by Grifols Sa News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$11.39
52 Week Low
$8.40
Market cap
5.8B
Dividend yield
0.00%
Volume
--
Avg. volume
168
P/E ratio
33.89